Hiroyuki Konno

Hiroyuki Konno

Auto-generated profile, based on publicly available information

Hiroyuki Konno

Department of Aging Control Medicine, Juntendo University Graduate School of Medicine, Bunkyo-Ku, Tokyo 113-0033, Japan

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2013 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
HKHiroyuki Konno
Hiroyuki Konno
YKYoshiaki Kanai
Yoshiaki Kanai
MKMikiyuki Katagiri
Mikiyuki Katagiri
TWTami Watanabe
Tami Watanabe
AMAkemi Mori
Akemi Mori
Takuji ShirasawaTakuji Shirasawa
Takuji Shirasawa
Melinjo (Gnetum gnemonL.) seed extract (MSE) containingtrans-resveratrol (3,5,4′-trihydroxy-trans-stilbene) and other derivatives exerts various beneficial effects. However, its mechanism of action in humans remains unknown. In this study, we aimed to investigate beneficial effects of MSE in healthy adult males. In this double-blind, randomized controlled study, 30 males aged 35–70 years with ≤10% flow-mediated dilatation received placebo or 750 mg MSE powder for 8 weeks, and twenty-nine males (45.1±8.8years old) completed the trial. There was a significant difference in the melinjo and placebo groups. Compared with the placebo control, MSE significantly reduced serum uric acid at 4 weeks and 8 weeks (n=14and 15, resp.). HDL cholesterol was significantly increased in the melinjo group. To clarify the mechanism of MSE for reducing uric acid, we investigated xanthine oxidase inhibitory activity, angiotensin II type 1 (AT1) receptor binding inhibition rate, and agonistic activities for PPARαand PPARγ. MSE,trans-resveratrol, and a resveratrol dimer, gnetin C (GC), significantly inhibit AT1 receptor binding and exhibit mild agonistic activities for PPARαand PPARγ. In conclusion, MSE may decrease serum uric acid regardless of insulin resistance and may improve lipid metabolism by increasing HDL cholesterol.

1 January 2012 in Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons)
Verified
Journal Article
Open access
PDF file
TSTakanori Sakaguchi
Takanori Sakaguchi
ASAtsushi Suzuki
Atsushi Suzuki
KIKeisuke Inaba
Keisuke Inaba
KFKazuhiko Fukumoto
Kazuhiko Fukumoto
SSShohachi Suzuki
Shohachi Suzuki
HKHiroyuki Konno
Hiroyuki Konno
われわれは肝硬変合併肝細胞癌に対する肝切除後大量腹水貯留に対して腹腔静脈シャントが著効した1例を経験したので報告する.症例は69歳,男性.15年間C型肝炎による肝機能異常にて近医通院.平成22年10月定期的CT検査で前尾側亜区域(S5)に1.5cmの腫瘍を指摘され,当科紹介された.肝障害度Aで12月S5亜区域切除を施行した.第5病日ドレーン抜去後腹水が貯留し始め,経口摂取や自力起座不能となった.急性腎不全や食道静脈瘤の出血を併発,3回の腹水ろ過濃縮還元後も改善傾向なく,第56病日に腹腔静脈シャントを作成した.MRSA感染によるシャント抜去,再留置を要したが,現在再発なく完全に自立した生活を送っている.肝切除後の不安定な肝機能状態にあっても,大量腹水に対する腹腔静脈シャントは考慮すべき方法であり,文献的考察を加えて報告する.